Anti-NDUFA8 antibody [EPR15303]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(7 Publications)
Rabbit Recombinant Monoclonal NDUFA8 antibody. Suitable for IP, WB and reacts with Human samples. Cited in 7 publications.
View Alternative Names
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8, Complex I-19kD, Complex I-PGIV, NADH-ubiquinone oxidoreductase 19 kDa subunit, CI-19kD, CI-PGIV, NDUFA8
- IP
Supplier Data
Immunoprecipitation - Anti-NDUFA8 antibody [EPR15303] (AB184952)
Western blot analysis of NDUFA8 in Human fetal heart lysate immunoprecipitated with ab184952 at 1/50 dilution (Lane 1). Lane 2 : PBS instead of Human fetal heart lysate.
Secondary : Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1500 dilution.
All lanes:
Immunoprecipitation - Anti-NDUFA8 antibody [EPR15303] (ab184952)
Predicted band size: 20 kDa
Observed band size: 17 kDa
false
- WB
Supplier Data
Western blot - Anti-NDUFA8 antibody [EPR15303] (AB184952)
All lanes:
Western blot - Anti-NDUFA8 antibody [EPR15303] (ab184952) at 1/20000 dilution
Lane 1:
Human fetal heart lysate at 20 µg
Lane 2:
Human fetal muscle lysate at 20 µg
Lane 3:
MCF7 cell lysate at 20 µg
Lane 4:
HepG2 cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugate at 1/1000 dilution
Predicted band size: 20 kDa
Observed band size: 17 kDa
false
Related conjugates and formulations (1)
-
Anti-NDUFA8 antibody [EPR15303] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
NDUFA8 participates in energy metabolism by facilitating the initial steps of the oxidative phosphorylation pathway. It is a subunit of Complex I also known as NADH:ubiquinone oxidoreductase one of the largest components in the mitochondrial inner membrane. This complex is important for the transfer of electrons from NADH to ubiquinone contributing to a process that generates ATP. NDUFA8 through its interaction within this complex helps regulate mitochondrial function and cellular energy balance.
Pathways
Energy metabolism involves the participation of NDUFA8 in the oxidative phosphorylation and mitochondrial electron transport chain pathways. These pathways are important for energy production in the form of ATP synthesis. NDUFA8 operates closely with other Complex I subunits and works in tandem with related complexes like Complexes II III and IV. Proteins such as NDUFA1 and NDUFB5 are important partners within these pathways ensuring the efficient execution of electron transport and ATP generation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (7)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:5133 PubMed40461459
2025
Applications
Unspecified application
Species
Unspecified reactive species
Science advances 10:eado5887 PubMed39454000
2024
Applications
Unspecified application
Species
Unspecified reactive species
RNA (New York, N.Y.) 30:223-239 PubMed38164626
2024
Applications
Unspecified application
Species
Unspecified reactive species
Antioxidants (Basel, Switzerland) 10: PubMed34943057
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in physiology 12:649461 PubMed33897458
2021
Applications
Unspecified application
Species
Unspecified reactive species
Clinical genetics 98:155-165 PubMed32385911
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 26:759-774.e5 PubMed30650365
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com